TUBERCULOSIS

Recommendations

Info

Pakistan population 2015 :: 189 million Estimates of TB burden, a 2015 Number (thousands) Rate (per 100 000 population) Mortality (excludes HIV+TB) 44 (9.3–110) 23 (4.9–56) Mortality (HIV+TB only) 1.6 (1.1–2.1) 0.83 (0.6–1.1) Incidence (includes HIV+TB) 510 (330–729) 270 (175–386) Incidence (HIV+TB only) 8.8 (5.4–13) 4.6 (2.8–6.9) Incidence (MDR/RR-TB) b 26 (16–36) 14 (8.5–19) Estimated TB incidence by age and sex (thousands), a 2015 0–14 years > 14 years Total Females 25 (12–37) 231 (141–320) 255 (153–357) Males 21 (13–29) 234 (163–305) 255 (175–335) Total 46 (30–61) 465 (357–573) 510 (330–729) Mortality (excludes HIV+TB) (Rate per 100 000 population per year) 100 75 50 25 0 2000 2005 2010 2015 TB case notifications, 2015 Total cases notified 331 809 Total new and relapse 323 856 — % tested with rapid diagnostics at time of diagnosis — % with known HIV status 4% — % pulmonary 81% — % bacteriologically confirmed among pulmonary 51% Universal health coverage and social protection TB treatment coverage (notified/estimated incidence), 2015 63% (44–98) TB patients facing catastrophic total costs TB case fatality ratio (estimated mortality/estimated incidence), 2015 0.09 (0.02–0.23) TB/HIV care in new and relapse TB patients, 2015 Number (%) Patients with known HIV-status who are HIV-positive 59
Philippines population 2015 :: 101 million Estimates of TB burden, a 2015 Number (thousands) Rate (per 100 000 population) Mortality (excludes HIV+TB) 14 (8.8–19) 13 (8.7–19) Mortality (HIV+TB only) 0.44 (0.24–0.7) 0.44 (0.24–0.7) Incidence (includes HIV+TB) 324 (279–373) 322 (277–370) Incidence (HIV+TB only) 4.3 (3.3–5.4) 4.3 (3.3–5.4) Incidence (MDR/RR-TB) b 17 (14–20) 17 (14–20) Estimated TB incidence by age and sex (thousands), a 2015 0–14 years > 14 years Total Females 14 (6.4–22) 100 (64–135) 114 (71–156) Males 17 (11–23) 194 (152–236) 211 (163–259) Total 31 (22–40) 294 (266–322) 324 (279–373) Mortality (excludes HIV+TB) (Rate per 100 000 population per year) 40 30 20 10 0 2000 2005 2010 2015 TB case notifications, 2015 Total cases notified 286 544 Total new and relapse 276 672 — % tested with rapid diagnostics at time of diagnosis 20% — % with known HIV status 13% — % pulmonary 97% — % bacteriologically confirmed among pulmonary 36% Universal health coverage and social protection TB treatment coverage (notified/estimated incidence), 2015 85% (74–99) TB patients facing catastrophic total costs TB case fatality ratio (estimated mortality/estimated incidence), 2015 0.04 (0.03–0.06) TB/HIV care in new and relapse TB patients, 2015 Number (%) Patients with known HIV-status who are HIV-positive 255
Page 1 and 2:
GLOBAL REPORT TUBERCULOSIS 2016
Page 3 and 4:
WHO Library Cataloguing-in-Publicat
Page 5 and 6:
:: Abbreviations aDSM AE AIDS ART A
Page 7 and 8:
The principal source of financial s
Page 9:
Zhumagali Ismailov, Sarah Jackson,
Page 12 and 13:
:: Executive Summary Background The
Page 14 and 15:
TB prevention services South Africa
Page 16 and 17:
Chapter 1 :: Introduction Tuberculo
Page 18 and 19:
:: Box 2.1 The Sustainable Developm
Page 20 and 21:
:: Box 2.3 The End TB Strategy at a
Page 22 and 23:
:: TABLE 2.1 Top 10 indicators (not
Page 24 and 25:
TABLE 2.2 :: The three TB high-burd
Page 26 and 27:
Chapter 3 :: TB disease burden :: K
Page 28 and 29:
:: Box 3.1 The WHO Global Task Forc
Page 30 and 31:
:: Box 3.2 Updates to estimates of
Page 32 and 33:
:: Box 3.3 Updated and interim esti
Page 34 and 35:
:: FIG. 3.1 Strengthening national
Page 36 and 37:
:: TABLE 3.2 Estimated epidemiologi
Page 38 and 39:
:: FIG. 3.3 Estimated TB incidence
Page 40 and 41:
:: FIG. 3.5 Global trends in the es
Page 42 and 43:
:: FIG. 3.8 Trends in estimated TB
Page 44 and 45:
:: FIG. 3.10a Top causes of death w
Page 46 and 47:
:: FIG. 3.14 Trends in estimated TB
Page 48 and 49:
:: FIG. 3.16 Data sources available
Page 50 and 51:
:: TABLE 3.5 Estimated incidence of
Page 52 and 53:
:: FIG. 3.20 Estimated incidence of
Page 54 and 55:
:: FIG. 3.22 Global progress in imp
Page 56 and 57:
:: TABLE 3.6 Number of TB cases fou
Page 58 and 59:
:: TABLE 3.7 HIV-negative and HIV-p
Page 60 and 61:
:: FIG. 3.29a The prevalence:notifi
Page 62 and 63:
:: FIG. 3.31b The average CFR by st
Page 64 and 65:
SIM and SINAN case-based databases,
Page 66 and 67:
Prompt and accurate diagnosis of tu
Page 68 and 69:
:: FIG. 4.2 New and relapse TB case
Page 70 and 71:
:: FIG. 4.5 Percentage of new and r
Page 72 and 73:
:: FIG. 4.8 Global numbers of notif
Page 74 and 75:
:: TABLE 4.4 National guidance in p
Page 76 and 77:
:: FIG. 4.9 Percentage of bacteriol
Page 78 and 79:
:: FIG. 4.12 Number of MDR/RR-TB ca
Page 80 and 81:
:: FIG. 4.14 Case notification rate
Page 82 and 83:
:: FIG. 4.16a The ten countries wit
Page 84 and 85:
:: Box 4.5 Community contributions
Page 86 and 87:
:: FIG. 4.18 Estimated ART treatmen
Page 88 and 89:
issued in March 2013 and updated in
Page 90 and 91:
:: FIG. 4.22 Treatment outcomes for
Page 92 and 93:
:: Box 4.6 Active TB drug-safety mo
Page 94 and 95:
Prevention of new infections of Myc
Page 96 and 97:
:: TABLE 5.2 TB preventive treatmen
Page 98 and 99:
:: TABLE 5.3 Provision of TB preven
Page 100 and 101:
:: FIG. 5.5 Coverage of BCG vaccina
Page 102 and 103:
This chapter aims to provide a tube
Page 104 and 105:
:: FIG. 6.2 Government spending on
Page 106 and 107:
:: Box 6.1 Implications for TB of e
Page 108 and 109:
:: Box 6.2 Innovations in engaging
Page 110 and 111:
:: Box 6.4 Reforming systems to exp
Page 112 and 113: :: TABLE 6.1 TB patient social supp
Page 114 and 115: :: FIG. 6.5 Surveys of costs faced
Page 116 and 117: :: TABLE 6.3 Status of selected SDG
Page 118 and 119: Continue current trend (base case s
Page 120 and 121: can provide insights into progress
Page 122 and 123: lion, most (US$ 4.4 billion, 67%) i
Page 124 and 125: :: Box 3.2 Updates to estimates of
Page 126 and 127: :: FIG. 7.5 Funding for NTP budgets
Page 128 and 129: :: Box 7.2 International donor fund
Page 130 and 131: :: FIG. 7.6 Reported funding gaps f
Page 132 and 133: :: Box 7.3 Methods used to estimate
Page 134 and 135: :: Box 8.1 WHO’s Global Action Fr
Page 136 and 137: is critical to allow for the time-s
Page 138 and 139: :: FIG. 8.2 The global development
Page 140 and 141: :: FIG. 8.3 The development pipelin
Page 142: Annex 1 Access to the WHO global TB
Page 145 and 146: A data dictionary that defines each
Page 147: Annex 2 Country profiles :: FOR 30
Page 150 and 151: Bangladesh population 2015 :: 161 m
Page 152 and 153: China population 2015 :: 1 376 mill
Page 154 and 155: Democratic Republic of the Congo po
Page 156 and 157: India population 2015 :: 1 311 mill
Page 158 and 159: Kenya population 2015 :: 46 million
Page 160 and 161: Myanmar population 2015 :: 54 milli
Page 164 and 165: Russian Federation population 2015
Page 166 and 167: Thailand population 2015 :: 68 mill
Page 168: Viet Nam population 2015 :: 93 mill
Page 171 and 172: Central African Republic population
Page 173 and 174: Lesotho population 2015 :: 2.1 mill
Page 175 and 176: Namibia population 2015 :: 2.5 mill
Page 177 and 178: Sierra Leone population 2015 :: 6.5
Page 179 and 180: Zimbabwe population 2015 :: 16 mill
Page 182 and 183: WHO African Region WHO MEMBER STATE
Page 184 and 185: WHO Eastern Mediterranean Region WH
Page 186 and 187: WHO South-East Asia Region WHO MEMB
Page 188: Annex 4 TB burden estimates, notifi
Page 191 and 192: :: TABLE A4.1 TB incidence estimate
Page 193 and 194: :: TABLE A4.1 Table TB incidence A4
Page 195 and 196: :: Table TABLE A4.2 A4.2 Estimates
Page 197 and 198: Table :: TABLE A4.2 A4.2 Estimates
Page 199 and 200: :: TABLE A4.3 Measured percentage o
Page 201 and 202: :: TABLE A4.3 Measured Table A4.3 p
Page 203 and 204: :: TABLE A4.4 TB case notifications
Page 205 and 206: :: TABLE A4.4 TB case notifications
Page 207 and 208: :: TABLE A4.5 Treatment outcomes by
Page 209 and 210: :: TABLE A4.5 Treatment outcomes by
Page 211: ISBN 9 789241 565394 Ending TB by 2
show all

TUBERCULOSIS

Create successful ePaper yourself

Delete template?

Save as template?